Eli Lilly Sued Over Marketing of Testosterone DrugSeptember 30, 2014

A suit filed in federal court in Newark claims Eli Lilly put users at risk by aggressively marketing testosterone replacement drug Axiron while failing to adequately warn about risks of heart attacks and strokes. The plaintiff, Patrick Miller of Hopatcong, N.J., began taking Axiron at age 54 in September 2012, and suffered a heart attack …